P & G Health Ltd

Market Cap: Mid Cap
Industry: Pharmaceuticals & Drugs
ISIN: INE199A01012
NSEID: PGHL
BSEID: 500126

INR

5,222.95

35.45 (0.68%)

BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 2.15 k

{
  "main_header": {
    "sid": 346859,
    "name": "P & G Health Ltd",
    "stock_name": "P & G Health Ltd",
    "full_name": "Procter & Gamble Health Ltd",
    "name_url": "stocks-analysis/p-g-health",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "5,222.95",
    "chg": 35.45,
    "chgp": "0.68%",
    "dir": 1,
    "prev_price": "5,187.50",
    "mcapval": "8,669.77 Cr",
    "mcap": "Mid Cap",
    "scripcode": 500126,
    "symbol": "PGHL",
    "ind_name": "Pharmaceuticals & Drugs",
    "ind_code": 4,
    "isin": "INE199A01012",
    "curr_date": "Apr 11, 12:53 PM",
    "curr_time": "00:07 AM",
    "bse_nse_vol": "2.15 k",
    "exc_status": "Active",
    "traded_date": "Apr 11, 2025",
    "traded_date_str": "2025 04 11",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://sandbox-www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/p-g-health-346859-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Procter & Gamble Health Faces Mixed Technical Trends Amid Market Evaluation Revision",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/procter-gamble-health-ltds-technical-trend-shifts-from-mildly-bullish-to-sideways-amid-stock-decline-1636801",
        "imagepath": "",
        "date": "2025-03-28 08:00:56",
        "description": "Procter & Gamble Health, a midcap player in the Pharmaceuticals & Drugs sector, has recently undergone an evaluation revision reflecting its current market dynamics. The stock is currently priced at 5044.90, down from a previous close of 5320.85, with a 52-week high of 5,835.95 and a low of 4,640.30. Today's trading saw a high of 5301.70 and a low of 4916.00.\n\nThe technical summary indicates a mixed performance across various indicators. The MACD shows a mildly bearish trend on both weekly and monthly scales, while the RSI indicates no signal for both periods. Bollinger Bands reflect a bearish stance weekly and mildly bearish monthly. Daily moving averages are mildly bullish, contrasting with the KST, which is mildly bearish on both timeframes. The Dow Theory suggests no trend weekly, with a mildly bearish outlook monthly. Interestingly, the On-Balance Volume (OBV) shows no trend weekly but is mildly bullis..."
      },
      {
        "title": "Procter & Gamble Health Faces Significant Stock Decline Amid Broader Market Gains",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/procter-gamble-health-stock-declines-6-15-underperforming-sector-by-4-44-1628281",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/3/ProcterGambleHe_priceRelatedfactors_825983.png",
        "date": "2025-03-27 14:30:19",
        "description": "Procter & Gamble Health's shares have declined significantly, underperforming the broader sector. The stock has faced consecutive losses, trading below key moving averages and showing a bearish trend. Despite recent downturns, it has recorded positive annual gains, though still trailing behind the Sensex's performance over the same period."
      },
      {
        "title": "Procter & Gamble Health Adjusts Market Evaluation Amid Mixed Technical Indicators",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/procter-gamble-health-downgraded-to-hold-rating-amid-stock-price-decline-1619704",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/3/ProcterGambleHe_mojoScore_815193.png",
        "date": "2025-03-27 08:03:58",
        "description": "Procter & Gamble Health has experienced a recent evaluation adjustment, reflecting its position in the Pharmaceuticals & Drugs sector. The company showcases strong management efficiency with a high return on equity and positive quarterly results, though it faces challenges in long-term growth and high stock valuation relative to earnings."
      },
      {
        "title": "Procter & Gamble Health Experiences Mixed Technical Trends Amid Market Evaluation Revision",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/procter-gamble-healths-technical-trend-changes-from-bullish-to-mildly-bullish-amid-stock-price-decline-1619415",
        "imagepath": "",
        "date": "2025-03-27 08:00:48",
        "description": "Procter & Gamble Health, a midcap player in the Pharmaceuticals & Drugs sector, has recently undergone an evaluation revision reflecting its current market dynamics. The stock is currently priced at 5320.85, down from a previous close of 5483.10, with a 52-week high of 5,835.95 and a low of 4,640.30. Today's trading saw a high of 5487.95 and a low of 5301.65.\n\nThe technical summary indicates a mixed performance across various indicators. The MACD shows a mildly bearish trend on a weekly basis while remaining bullish monthly. The Relative Strength Index (RSI) shows no significant signals for both weekly and monthly periods. Bollinger Bands reflect a sideways trend weekly, with a bullish stance monthly. Daily moving averages are bullish, while the KST indicates a mildly bearish trend weekly but bullish monthly. The Dow Theory suggests a mildly bullish trend weekly, with no clear trend monthly. The On-Balance ..."
      },
      {
        "title": "Procter & Gamble Health Adjusts Evaluation Amid Positive Technical Trends and Strong Metrics",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/procter-gamble-health-upgraded-to-buy-as-stock-shows-bullish-trend-1541970",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/3/ProcterGambleHe_mojoScore_747080.png",
        "date": "2025-03-21 08:01:05",
        "description": "Procter & Gamble Health has recently experienced a change in evaluation, reflecting a shift in its technical trends. The company shows resilience with a year-to-date return of 2.04% and strong management efficiency, highlighted by a high return on equity and low debt-to-equity ratio, indicating a favorable position within its sector."
      },
      {
        "title": "Procter & Gamble Health Shows Mixed Technical Trends Amid Strong Long-Term Performance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/procter-gamble-healths-technical-trend-shifts-from-mildly-bullish-to-bullish-amid-stock-price-increase-1542055",
        "imagepath": "",
        "date": "2025-03-21 08:00:48",
        "description": "Procter & Gamble Health, a midcap player in the Pharmaceuticals & Drugs industry, has recently undergone an evaluation revision reflecting its current market dynamics. The stock is currently priced at 5,337.00, showing a notable increase from the previous close of 5,221.70. Over the past year, Procter & Gamble Health has demonstrated a stock return of 10.49%, outperforming the Sensex, which recorded a return of 5.89% in the same period.\n\nThe technical summary indicates a mixed performance across various indicators. The Moving Averages signal a bullish trend on a daily basis, while the MACD shows a mildly bearish stance on a weekly basis but bullish on a monthly scale. The Bollinger Bands reflect a sideways trend weekly, transitioning to bullish monthly. Additionally, the On-Balance Volume (OBV) suggests a mildly bullish trend over both weekly and monthly periods.\n\nIn terms of returns, Procter & Gamble Healt..."
      },
      {
        "title": "Procter & Gamble Health Shows Mixed Technical Trends Amid Market Volatility",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/procter-gamble-healths-technical-trend-shifts-from-sideways-to-mildly-bullish-amid-stock-price-increase-1228942",
        "imagepath": "",
        "date": "2025-03-07 08:01:32",
        "description": "Procter & Gamble Health, a midcap player in the Pharmaceuticals & Drugs industry, has recently undergone an evaluation revision reflecting its current market dynamics. The stock is currently priced at 5165.80, showing a slight increase from the previous close of 5090.10. Over the past year, the stock has reached a high of 5,835.95 and a low of 4,640.30, indicating a degree of volatility.\n\nIn terms of technical indicators, the weekly MACD and KST suggest a mildly bearish sentiment, while the monthly Bollinger Bands indicate a bullish trend. The daily moving averages, however, reflect a mildly bullish outlook, showcasing mixed signals across different time frames. Notably, the Relative Strength Index (RSI) shows no significant signals for both weekly and monthly assessments.\n\nWhen comparing the stock's performance to the Sensex, Procter & Gamble Health has shown varied returns. Over the past year, the stock h..."
      },
      {
        "title": "Procter & Gamble Health Faces Mixed Technical Signals Amid Market Volatility",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/procter-gamble-healths-technical-trend-shifts-from-mildly-bullish-to-sideways-amid-stock-decline-7-1170714",
        "imagepath": "",
        "date": "2025-03-03 08:00:51",
        "description": "Procter & Gamble Health, a midcap player in the Pharmaceuticals & Drugs industry, has recently undergone an evaluation revision reflecting its current market dynamics. The stock is currently priced at 4,996.95, down from a previous close of 5,285.00. Over the past year, the stock has seen a high of 5,835.95 and a low of 4,640.30, indicating a degree of volatility.\n\nThe technical summary reveals mixed signals across various indicators. The MACD shows a mildly bearish trend on a weekly basis, while it remains bullish on a monthly scale. The Relative Strength Index (RSI) indicates no significant signals for both weekly and monthly periods. Bollinger Bands and KST are both bearish on a weekly basis, with KST also reflecting a bearish stance monthly. Moving averages present a mildly bullish outlook daily, contrasting with the overall bearish sentiment in other indicators.\n\nIn terms of performance, Procter & Gamb..."
      },
      {
        "title": "Procter & Gamble Health Faces Mixed Technical Trends Amid Market Evaluation Revision",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/procter-gamble-healths-technical-trend-shifts-from-mildly-bullish-to-sideways-amid-stock-decline-4-1163441",
        "imagepath": "",
        "date": "2025-03-02 08:00:50",
        "description": "Procter & Gamble Health, a midcap player in the Pharmaceuticals & Drugs industry, has recently undergone an evaluation revision reflecting its current market dynamics. The stock is currently priced at 4,996.95, down from a previous close of 5,285.00, with a 52-week high of 5,835.95 and a low of 4,640.30. Today's trading saw a high of 5,258.00 and a low of 4,916.50.\n\nThe technical summary indicates a mixed performance across various indicators. The MACD shows a mildly bearish trend on a weekly basis while remaining bullish on a monthly scale. The Relative Strength Index (RSI) presents no signals for both weekly and monthly assessments. Bollinger Bands and KST reflect bearish tendencies on both timeframes, while moving averages indicate a mildly bullish stance daily.\n\nIn terms of returns, Procter & Gamble Health has faced challenges compared to the Sensex. Over the past week, the stock returned -5.63%, while ..."
      }
    ],
    "total": 41,
    "sid": "346859",
    "stock_news_url": "https://sandbox-www.marketsmojo.com/news/procter-gamble-health-346859"
  },
  "announcements": [
    {
      "caption": "Closure of Trading Window",
      "datetime": "26-Mar-2025",
      "details": "Dear Sir Please find attached intimation regarding closure of Companys trading window for Directors and Designated employees.",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Intimation for Intimation Of Board Meeting Scheduled To Be Held On May 29 2025",
      "datetime": "26-Mar-2025",
      "details": "Procter & Gamble Health Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2025 inter alia to consider and approve In terms of Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we would like to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Thursday May 29 2025 inter alia to consider and approve Audited Financial Statements for the Financial Year ended March 31 2025 and to consider recommendation of dividend (if any).",
      "source": "BSE"
    },
    {
      "caption": "Shareholder Meeting / Postal Ballot-Notice of Postal Ballot",
      "datetime": "10-Mar-2025",
      "details": "Dear Sir Please find attached notice of postal ballot along with postal ballot form for seeking approval of the members of the Company on the agenda items mentioned in the postal ballot notice.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "",
      "data": [
        {
          "title": "BOARD MEETING",
          "txt": "29 May 2025"
        }
      ]
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Procter & Gamble Health Ltd has declared <strong>800%</strong> dividend, ex-date: 21 Feb 25",
          "dt": "2025-02-21",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Procter & Gamble Health Faces Mixed Technical Trends Amid Market Evaluation Revision

2025-03-28 08:00:56

Procter & Gamble Health, a midcap player in the Pharmaceuticals & Drugs sector, has recently undergone an evaluation revision reflecting its current market dynamics. The stock is currently priced at 5044.90, down from a previous close of 5320.85, with a 52-week high of 5,835.95 and a low of 4,640.30. Today's trading saw a high of 5301.70 and a low of 4916.00. The technical summary indicates a mixed performance across various indicators. The MACD shows a mildly bearish trend on both weekly and monthly scales, while the RSI indicates no signal for both periods. Bollinger Bands reflect a bearish stance weekly and mildly bearish monthly. Daily moving averages are mildly bullish, contrasting with the KST, which is mildly bearish on both timeframes. The Dow Theory suggests no trend weekly, with a mildly bearish outlook monthly. Interestingly, the On-Balance Volume (OBV) shows no trend weekly but is mildly bullis...

Procter & Gamble Health Faces Significant Stock Decline Amid Broader Market Gains

2025-03-27 14:30:19

Procter & Gamble Health's shares have declined significantly, underperforming the broader sector. The stock has faced consecutive losses, trading below key moving averages and showing a bearish trend. Despite recent downturns, it has recorded positive annual gains, though still trailing behind the Sensex's performance over the same period.

Procter & Gamble Health Adjusts Market Evaluation Amid Mixed Technical Indicators

2025-03-27 08:03:58

Procter & Gamble Health has experienced a recent evaluation adjustment, reflecting its position in the Pharmaceuticals & Drugs sector. The company showcases strong management efficiency with a high return on equity and positive quarterly results, though it faces challenges in long-term growth and high stock valuation relative to earnings.

Procter & Gamble Health Experiences Mixed Technical Trends Amid Market Evaluation Revision

2025-03-27 08:00:48

Procter & Gamble Health, a midcap player in the Pharmaceuticals & Drugs sector, has recently undergone an evaluation revision reflecting its current market dynamics. The stock is currently priced at 5320.85, down from a previous close of 5483.10, with a 52-week high of 5,835.95 and a low of 4,640.30. Today's trading saw a high of 5487.95 and a low of 5301.65. The technical summary indicates a mixed performance across various indicators. The MACD shows a mildly bearish trend on a weekly basis while remaining bullish monthly. The Relative Strength Index (RSI) shows no significant signals for both weekly and monthly periods. Bollinger Bands reflect a sideways trend weekly, with a bullish stance monthly. Daily moving averages are bullish, while the KST indicates a mildly bearish trend weekly but bullish monthly. The Dow Theory suggests a mildly bullish trend weekly, with no clear trend monthly. The On-Balance ...

Procter & Gamble Health Adjusts Evaluation Amid Positive Technical Trends and Strong Metrics

2025-03-21 08:01:05

Procter & Gamble Health has recently experienced a change in evaluation, reflecting a shift in its technical trends. The company shows resilience with a year-to-date return of 2.04% and strong management efficiency, highlighted by a high return on equity and low debt-to-equity ratio, indicating a favorable position within its sector.

Procter & Gamble Health Shows Mixed Technical Trends Amid Strong Long-Term Performance

2025-03-21 08:00:48

Procter & Gamble Health, a midcap player in the Pharmaceuticals & Drugs industry, has recently undergone an evaluation revision reflecting its current market dynamics. The stock is currently priced at 5,337.00, showing a notable increase from the previous close of 5,221.70. Over the past year, Procter & Gamble Health has demonstrated a stock return of 10.49%, outperforming the Sensex, which recorded a return of 5.89% in the same period. The technical summary indicates a mixed performance across various indicators. The Moving Averages signal a bullish trend on a daily basis, while the MACD shows a mildly bearish stance on a weekly basis but bullish on a monthly scale. The Bollinger Bands reflect a sideways trend weekly, transitioning to bullish monthly. Additionally, the On-Balance Volume (OBV) suggests a mildly bullish trend over both weekly and monthly periods. In terms of returns, Procter & Gamble Healt...

Procter & Gamble Health Shows Mixed Technical Trends Amid Market Volatility

2025-03-07 08:01:32

Procter & Gamble Health, a midcap player in the Pharmaceuticals & Drugs industry, has recently undergone an evaluation revision reflecting its current market dynamics. The stock is currently priced at 5165.80, showing a slight increase from the previous close of 5090.10. Over the past year, the stock has reached a high of 5,835.95 and a low of 4,640.30, indicating a degree of volatility. In terms of technical indicators, the weekly MACD and KST suggest a mildly bearish sentiment, while the monthly Bollinger Bands indicate a bullish trend. The daily moving averages, however, reflect a mildly bullish outlook, showcasing mixed signals across different time frames. Notably, the Relative Strength Index (RSI) shows no significant signals for both weekly and monthly assessments. When comparing the stock's performance to the Sensex, Procter & Gamble Health has shown varied returns. Over the past year, the stock h...

Procter & Gamble Health Faces Mixed Technical Signals Amid Market Volatility

2025-03-03 08:00:51

Procter & Gamble Health, a midcap player in the Pharmaceuticals & Drugs industry, has recently undergone an evaluation revision reflecting its current market dynamics. The stock is currently priced at 4,996.95, down from a previous close of 5,285.00. Over the past year, the stock has seen a high of 5,835.95 and a low of 4,640.30, indicating a degree of volatility. The technical summary reveals mixed signals across various indicators. The MACD shows a mildly bearish trend on a weekly basis, while it remains bullish on a monthly scale. The Relative Strength Index (RSI) indicates no significant signals for both weekly and monthly periods. Bollinger Bands and KST are both bearish on a weekly basis, with KST also reflecting a bearish stance monthly. Moving averages present a mildly bullish outlook daily, contrasting with the overall bearish sentiment in other indicators. In terms of performance, Procter & Gamb...

Procter & Gamble Health Faces Mixed Technical Trends Amid Market Evaluation Revision

2025-03-02 08:00:50

Procter & Gamble Health, a midcap player in the Pharmaceuticals & Drugs industry, has recently undergone an evaluation revision reflecting its current market dynamics. The stock is currently priced at 4,996.95, down from a previous close of 5,285.00, with a 52-week high of 5,835.95 and a low of 4,640.30. Today's trading saw a high of 5,258.00 and a low of 4,916.50. The technical summary indicates a mixed performance across various indicators. The MACD shows a mildly bearish trend on a weekly basis while remaining bullish on a monthly scale. The Relative Strength Index (RSI) presents no signals for both weekly and monthly assessments. Bollinger Bands and KST reflect bearish tendencies on both timeframes, while moving averages indicate a mildly bullish stance daily. In terms of returns, Procter & Gamble Health has faced challenges compared to the Sensex. Over the past week, the stock returned -5.63%, while ...

View All News

Announcement

Closure of Trading Window

26-Mar-2025 | Source : BSE

Dear Sir Please find attached intimation regarding closure of Companys trading window for Directors and Designated employees.

Board Meeting Intimation for Intimation Of Board Meeting Scheduled To Be Held On May 29 2025

26-Mar-2025 | Source : BSE

Procter & Gamble Health Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2025 inter alia to consider and approve In terms of Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we would like to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Thursday May 29 2025 inter alia to consider and approve Audited Financial Statements for the Financial Year ended March 31 2025 and to consider recommendation of dividend (if any).

Shareholder Meeting / Postal Ballot-Notice of Postal Ballot

10-Mar-2025 | Source : BSE

Dear Sir Please find attached notice of postal ballot along with postal ballot form for seeking approval of the members of the Company on the agenda items mentioned in the postal ballot notice.